133 related articles for article (PubMed ID: 21118408)
1. Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location.
Prestidge T; Lee S; Harper P; Young L; Ockelford P
Intern Med J; 2012 Jan; 42(1):71-4. PubMed ID: 21118408
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy.
Hitos K; Wain GV; Fletcher JP
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):23-7. PubMed ID: 21951130
[TBL] [Abstract][Full Text] [Related]
3. Postoperative venous thromboembolism predicts survival in cancer patients.
Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
[TBL] [Abstract][Full Text] [Related]
4. Use of inferior vena caval filters and survival in patients with malignancy.
Wallace MJ; Jean JL; Gupta S; Eapen GA; Johnson MM; Ahrar K; Madoff DC; Morello FA; Murthy R; Hicks ME
Cancer; 2004 Oct; 101(8):1902-7. PubMed ID: 15386336
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in cancer patients in Christchurch, 1995-1999.
Joung S; Robinson B
N Z Med J; 2002 Jun; 115(1155):257-60. PubMed ID: 12117159
[TBL] [Abstract][Full Text] [Related]
7. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
11. Prevention of venous thromboembolism in cancer patients.
Kakkar AK; Williamson RC
Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and survival in patients with high-grade glioma.
Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy with low molecular weight heparin in cancer patients.
Petralia P; Kakkar AK
Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
[TBL] [Abstract][Full Text] [Related]
14. [The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].
Malý R; Vodicková L
Vnitr Lek; 2004 Oct; 50(10):751-5. PubMed ID: 15633930
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism and cancer: risks and outcomes.
Lee AY; Levine MN
Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
[TBL] [Abstract][Full Text] [Related]
16. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
[TBL] [Abstract][Full Text] [Related]
18. Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.
Isma N; Svensson PJ; Gottsäter A; Lindblad B
Thromb Res; 2010 Jun; 125(6):e335-8. PubMed ID: 20406709
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary embolism in cancer: clinical analysis of 60 cases].
Li G; Lu WX; Wang C
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):550-3. PubMed ID: 19950707
[TBL] [Abstract][Full Text] [Related]
20. Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
van Doormaal FF; Cohen AT; Davidson BL; Decousus H; Gallus AS; Gent M; Piovella F; Prins MH; Raskob GE; Büller HR
Thromb Haemost; 2010 Jul; 104(1):86-91. PubMed ID: 20508907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]